ABASAGLAR 100 units/ml KwikPen, solution for injection in a pre-filled pen 5 pens of 3 ml
Active ingredients: Insulin glargine
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 pens of 3 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ABASAGLAR 100 unités/mL KwikPen, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 5 cartouche(s) en verre de 3 ml dans stylo jetable Kwikpen (injection de 1 à 80 unités)
- Marketing authorisation holder
- ELI LILLY NEDERLAND (PAY-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Apr 2017
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64332894CIP73004007CIP133400930040072Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INSULINE GLARGINEsolution | 100 unités · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.